John Hsu

GenMark Diagnostics, Inc (NASDAQ: GNMK) surged 12 percent Wednesday after announcing FDA market clearance for its ePlex Blood Culture Identification Fungal Pathogen Panel. The news bolstered Raymond James' bullish thesis for the stock.  The Analyst Raymond James analyst John Hsu ...